| Date & Time | 19 May 2025 at 14:30-17:30 |
|---|---|
| Address | Auditório da ULS Loures Odivelas Av. Carlos Teixeira 3, 2674-514 Loures |
| Location | Loures, Portugal |
VectorB2B, ULS Coimbra and IdiPAZ invite you all to attend the workshop: Transition from Preclinical Research to Clinical Trials
The transition from preclinical research to clinical trials is a crucial step in developing new therapies and drugs. This event brings together key stakeholders, including researchers, industry leaders, regulatory bodies, and patient associations, to discuss the scientific, regulatory, and operational challenges. We will explore strategies to optimise the journey from bench to bedside, ensuring safety, efficacy and patient-centred innovation.
Agenda
14:00 – 14:30 Reception & Coffee Networking
14:30 – 14:45 Event Opening Ana Custódio (Co-CEO, VectorB2B)
14:45 – 15:30 Panel 1: Success Stories – Real Experiences Moderator: Tiago Alfaro (Pneumologist, ULS Coimbra)
- Clara Leandro (Scientific Director, Technophage SA)
- Ana Vieira (Liga Portuguesa Contra as Doenças Reumáticas)
- Rita Leal (Nefrologist, ULS Coimbra)
- Susana Saraiva (Coordinator of the Research and Innovation Center, ULSLOD)
15:30 – 16:15 Panel 2: Challenges in the Transition from Preclinical Research to Clinical Trials Moderator: João Ribeiro (Head of Clinical Services, VectorB2B)
- Pablo G. Feijoo (Neurosurgeon, Hospital Universitario La Paz)
- Francisco Branco (Oncologist, ULSLOD)
- Mariana Barbosa (Researcher, UCIBIO/NOVA FCT)
- António Roldão (Head of Cell-based Vaccines Development Lab, IBET)
16:15 – 16:30 Coffee Break & Networking
16:30 – 17:15 Roundtable: How to Improve Transition Efficiency?
- All speakers
17:15 – 17:30 Conclusions & Next Steps
